Share this article
Share this article
ResearchAndMarkets.com s offering.
The Non-Viral Drug Delivery Systems: Focus on Intracellular Technologies and Intracellular Biologics Market, 2021-2030 report features an extensive study of the current landscape and the likely future opportunities in intracellular drug delivery technologies market for the next 10 years.
One of the key objectives of the report was to estimate the existing market size and identify potential future growth opportunities for intracellular drug delivery technologies. Based on likely licensing deal structures and agreements that are expected to be signed in the foreseen future, we have provided an informed estimate on the evolution of the market over the period 2021-2030.
네이버 인건비 부담 영업이익 감소, 매출은 29 8% 증가 metroseoul.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from metroseoul.co.kr Daily Mail and Mail on Sunday newspapers.
News | April 14, 2021
Air Products Acquires Remaining 50% Stake In Gasification Technology Joint Venture From China Shenhua Coal To Liquid And Chemical
Transaction Brings Air Products Ownership to 100%, Furthering its Gasification Growth Strategy and Position to Leverage its Complete Technology Portfolio
Lehigh Valley, PA and Shanghai /PRNewswire/ - Air Products (NYSE: APD) today announced it has completed the acquisition of the remaining 50 percent equity stake in its gasification technology joint venture (JV) with China Shenhua Coal to Liquid and Chemical Co. Ltd., a subsidiary of China Energy Group. Financial terms of the transaction are not being disclosed.
Air Products acquired its initial 50 percent equity stake in the JV as part of its acquisition of General Electric Company s ( GE ) gasification business from GE Power in 2019.
Search jobs 12-Apr-2021 [2021] Saline Laxatives Market is Expected to Surge with 5.0% CAGR With US$ 613.3 Million by 2027 – Coherent Market Insights
SEATTLE, April 12, 2021, (PHARMIWEB) The global saline laxatives market, by Age Group (Pediatric and Adult), By Route of Administration (Oral and Rectal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), accounted for US$ 396.3 million in 2019, and is projected to witness a CAGR of 5.0% over the forecast period (2019-2027).
To learn more about this report, request a sample copy The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
InvestaX, pioneers and creators of next generation technology driven investment products, announces the launch of the world’s first Digital SPACs, using smart contracts and blockchain technologies.